PCED1B-AS1: A Promising Drug Target / Biomarker (G100233209)

Target Name: PCED1B-AS1

NCBI ID: G100233209

PCED1B-AS1

Other Name(s): PCED1B antisense RNA 1

PCED1B-AS1: A Promising Drug Target / Biomarker

PCED1B-AS1 is a protein that is expressed in the brain and is involved in the regulation of pain signaling. It has been shown to play a role in the development of chronic pain conditions, and is Therefore, it is a potential drug target or biomarker for the treatment of such conditions.

The Protein

PCED1B-AS1 is a member of the PCED1B family of proteins, which are known for their role in the regulation of pain signaling. These proteins are involved in the production of pain signaling molecules, such as neuropeptides, which are released by neurons in response to pain.

PCED1B-AS1 is a 21-kDa protein that is expressed in the brain and is primarily localized to the postsynaptic density of neuronal axons in the brain. It is involved in the regulation of the release of neuropeptides, and has been shown to play a role in the development of chronic pain conditions.

The Potential Drug Target

PCED1B-AS1 is a potential drug target for the treatment of chronic pain conditions because of its involvement in the regulation of pain signaling. Chronic pain conditions, such as fibromyalgia and chronic low back pain, can be difficult to treat and can have a significant impact on a person's quality of life.

Studies have shown that PCED1B-AS1 plays a role in the development of chronic pain conditions by regulating the release of neuropeptides. By inhibiting the activity of PCED1B-AS1, it may be possible to reduce the production of neuropeptides and decrease the pain that a person experiences.

Another Potential Biomarker

PCED1B-AS1 may also be a potential biomarker for the diagnosis and monitoring of chronic pain conditions. The level of PCED1B-AS1 in a person's brain can be measured, and levels of PCED1B-AS1 have been shown to be elevated in individuals with chronic pain conditions.

By studying the levels of PCED1B-AS1 in individuals with chronic pain conditions, researchers may be able to determine whether PCED1B-AS1 is a reliable biomarker for the diagnosis and monitoring of these conditions. This information could be valuable for the development of new treatments for chronic pain conditions.

Conclusion

PCED1B-AS1 is a protein that is involved in the regulation of pain signaling and has been shown to play a role in the development of chronic pain conditions. It is a potential drug target or biomarker for the treatment of such conditions, and may be a valuable tool for the development of new treatments for chronic pain. Further research is needed to fully understand the role of PCED1B-AS1 in pain signaling and its potential as a drug target or biomarker.

Protein Name: PCED1B Antisense RNA 1

The "PCED1B-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCED1B-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets